Cargando…

Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy

The ability to cryopreserve natural killer (NK) cells has a significant potential in modern cancer immunotherapy. Current cryopreservation protocols cause deterioration in NK cell viability and functionality. This work reports the preservation of human cytokine‐activated NK cell viability and functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Assal, Rami, Abou‐Elkacem, Lotfi, Tocchio, Alessandro, Pasley, Shannon, Matosevic, Sandro, Kaplan, David L., Zylberberg, Claudia, Demirci, Utkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425501/ https://www.ncbi.nlm.nih.gov/pubmed/30937270 http://dx.doi.org/10.1002/advs.201802045

Ejemplares similares

Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
por: Matosevic, Sandro
Publicado: (2018)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
por: Lupo, Kyle B., et al.
Publicado: (2020)

Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
por: Wang, Jiao, et al.
Publicado: (2018)

3-D Microwell Array System for Culturing Virus Infected Tumor Cells
por: El Assal, Rami, et al.
Publicado: (2016)

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
por: Chambers, Andrea M., et al.
Publicado: (2018)

Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
por: Chambers, Andrea M., et al.
Publicado: (2019)

NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma
por: Wang, Jiao, et al.
Publicado: (2019)

Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
por: Chambers, Andrea M., et al.
Publicado: (2018)

Engineering cancer microenvironments for in vitro 3-D tumor models
por: Asghar, Waseem, et al.
Publicado: (2015)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Nanoparticle‐Mediated Intracellular Protection of Natural Killer Cells Avoids Cryoinjury and Retains Potent Antitumor Functions
por: Yao, Xue, et al.
Publicado: (2020)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
por: Wu, Xinyu, et al.
Publicado: (2022)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

Natural Killer Cells: Angels and Devils for Immunotherapy
por: Martín-Antonio, Beatriz, et al.
Publicado: (2017)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Natural Killer Cell-Mediated Immunotherapy for Leukemia
por: Allison, Michaela, et al.
Publicado: (2022)

Engineering Anisotropic Biomimetic Fibrocartilage Microenvironment by Bioprinting Mesenchymal Stem Cells in Nanoliter Gel Droplets
por: Gurkan, Umut A., et al.
Publicado: (2014)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
por: Rezvani, Katayoun, et al.
Publicado: (2015)

New Directions for Natural Killer T Cells in the Immunotherapy of Cancer
por: Teyton, Luc
Publicado: (2017)

Pharmacological targeting of natural killer cells for cancer immunotherapy
por: Miyazato, Kiho, et al.
Publicado: (2020)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
por: Shaver, Kari A., et al.
Publicado: (2021)

Natural killer cells: a promising immunotherapy for cancer
por: Chu, Junfeng, et al.
Publicado: (2022)

Natural killer cells: the next wave in cancer immunotherapy
por: Chen, Xin, et al.
Publicado: (2022)

Next Generation Natural Killer Cells for Cancer Immunotherapy
por: Rossi, Fiorella, et al.
Publicado: (2022)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Natural Killer Cell-Based Immunotherapy against Glioblastoma
por: Morimoto, Takayuki, et al.
Publicado: (2023)

Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor Immunotherapy
por: Mu, Dan, et al.
Publicado: (2022)

Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors
por: Chambers, Andrea M, et al.
Publicado: (2022)

Natural and bioinspired nanostructured bactericidal surfaces
por: Tripathy, Abinash, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lrr2c4hbupadbr9clq42r4e9n4